Trial Profile
Sequential therapy with vonoprazan, amoxicillin 7 days and vonoprazan, metronidazole, and sitafloxacin 7 days versus triple therapy with vonoprazan, amoxicillin, and metronidazole 7days for early age Helicobacter pylori infection: a multicentre, open-label, randomised trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2020
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Metronidazole (Primary) ; Sitafloxacin (Primary) ; Vonoprazan (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 05 Sep 2018 Status changed from not yet recruiting to recruiting.
- 10 Apr 2018 New trial record